HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Unilever/Helene Curtis merger

This article was originally published in The Rose Sheet

Executive Summary

Unilever/Helene Curtis merger: Unilever completes cash tender offer of $70 a share for 6.4 mil. of Helene Curtis' 11 mil. outstanding common shares, the firm said March 19. Unilever also expects to purchase 2.6 mil. Class B common stock shares from the Gidwitz family for $70/share and an additional 2 mil. shares by March 22, giving the Anglo-Dutch consumer products company control of over 90% of Helene Curtis' outstanding shares. Unilever's cash tender offer closed March 18. The two companies announced Unilever's acquisition of Helene Curtis for $770 mil. plus the assumption of $145 in debt Feb. 13 ("The Rose Sheet" Feb. 19, p. 1)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel